Delivery Order SPE2DB22D2206-SPE2DB24FKM27

Award Date 9/27/24
Potential Completion Date 9/30/24
Potential Value $3.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 0.3 mg/mL buprenorphine vials. The contract has a ceiling value of $1,389.00 and a period of performance ending on June 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the...
This federal contract award is for the delivery of BUPRENORPHINE 0.3 MG/ML VIALML to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is a firm fixed price delivery order with a potential value of $1,389.00 and a completion date of February 29, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,521.84 firm fixed-price delivery order is for the supply of BUPRENORPHINE-NALOX 8-2MG FILM 30S, a medication used for the treatment of opioid use disorder. The contract has an ultimate completion date of March 4, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp for the delivery of Buprenorphine 20 mcg/hr Patch 4s, a specialty pharmaceutical product. The contract, valued at $1,060.77, has an ultimate completion date of April 21, 2023. AmerisourceBergen, a major pharmaceutical distributor, maintains a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,119.40 firm fixed-price delivery order is for 4563118550 Buprenorphine 15 MCG/HR Patch 4S, a specialty medication. The award has an ultimate completion date of December 18, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
The Defense Logistics Agency Troop Support Medical awarded a $138,900 delivery order to Amerisourcebergen Drug Corporation for Buprenorphine 0.3 mg/ml 5ml syringes. The firm fixed price order is for product delivery to a location in Conshohocken, Pennsylvania between August 2nd and August 3rd, 2023. Amerisourcebergen will fulfill the order as the prime contractor. The Defense Logistics Agency manages the Department of Defense's global supply chain and supports military treatment facilities and...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,763.88 firm fixed-price delivery order is for the supply of 4566552120 buprenorphine-naloxone 8-2mg film in 30-count packages, with a completion date of November 27, 2024. The contract is an Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a primary...
The Defense Logistics Agency awarded a $272,850 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 30 packages containing 4-1mg films of buprenorphine-naloxone. The place of performance for this single award delivery order is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The order period of performance spans from July 21, 2023 through July 24, 2023. No major subcontractors or set aside designations were identified. This delivery order...
The Defense Logistics Agency awarded a $411,440 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 30 units of 8-2mg films of buprenorphine-naloxone. The place of performance for this single-day contract is Amerisourcebergen's corporate office in Conshohocken, Pennsylvania. As a major provider of pharmaceuticals to the Department of Defense, this award supports DLA's mission to provide an efficient and effective global supply chain for America's armed forces....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,971.45 firm fixed-price delivery order is for the supply of NALBUPHINE 100 MG/10 ML VIAL 10ML, a pharmaceutical product. The contract has a completion date of February 4, 2025 and was awarded on February 3, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FKM27
    Delivery Order

This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of Buprenorphine 0.3 mg/mL vials. The delivery order, valued at $3,472.50, has a firm-fixed-price contract type and a period of performance through September 30, 2024. Amerisourcebergen, a major pharmaceutical distributor, was awarded this order as part of a larger indefinite delivery contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a comprehensive range of medical commodities, including prescription drugs and medical supplies, to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 12/27/24, 9:01 AM